BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6577015)

  • 1. Bone scintigraphy in patients with osteogenic sarcoma. Cooperative Osteogenic Sarcoma Study Group COSS 80.
    Knop J; Montz R
    J Cancer Res Clin Oncol; 1983; 106 Suppl():49-50. PubMed ID: 6577015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma.
    Yeh SD; Rosen G; Caparros B; Benua RS
    Clin Nucl Med; 1984 Apr; 9(4):175-83. PubMed ID: 6233055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of computed medical imaging in the surveillance of neo-adjuvant chemotherapy of osteogenic osteosarcoma in children and adolescents. 51 patients seen from 1984 to 1986].
    Delepine N; Desbois JC; Delepine G; Cornille H; Mundler O; Fauchet M; Roger B; Laval-Jeantet M
    Ann Med Interne (Paris); 1987; 138(4):275-7. PubMed ID: 3307589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
    Menendez LR; Fideler BM; Mirra J
    J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of chemotherapy on the retention of 99mTc-methylenediphosphonate by the osteogenic sarcoma of the mouse (author's transl)].
    Senekowitsch R; Kriegel H
    Nuklearmedizin; 1980 Aug; 19(4):200-5. PubMed ID: 6937874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma.
    Springfield D
    J Bone Joint Surg Am; 1993 Dec; 75(12):1880-1. PubMed ID: 8258559
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma.
    Edeline V; Frouin F; Bazin JP; Di Paola M; Kalifa C; Contesso G; Parmentier C; Lumbroso J; Di Paola R
    Eur J Nucl Med; 1993 Dec; 20(12):1175-85. PubMed ID: 8299653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
    Shapeero LG; Henry-Amar M; Vanel D
    Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of bone scintigraphy in the diagnosis and treatment of osteogenic sarcoma.
    Zwas ST
    Prog Clin Biol Res; 1982; 99():43-8. PubMed ID: 6959161
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of bone scintigraphy in osteogenic sarcoma.
    Rees CR; Siddiqui AR; duCret R
    Skeletal Radiol; 1986; 15(5):365-7. PubMed ID: 3090705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scintigraphy with 99mTc-MIBI for assessment of tumor response to preoperative chemotherapy in patients with osteosarcoma].
    García-Fernández R; Hernández-Hernández DM; Iwasaki-Otake L; Mantilla-Morales A; Ortiz-Rodríguez L; Pichardo-Romero P; Lira-Puerto V
    Rev Invest Clin; 2001; 53(4):324-9. PubMed ID: 11599479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of radionuclide bone imaging in selected patients with osteogenic sarcoma metastatic to lung.
    Kirks DR; McCook TA; Merten DF; Sullivan DC
    Pediatr Radiol; 1980 Apr; 9(3):139-43. PubMed ID: 6930625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of bone scintigraphy in the follow-up of osteogenic sarcoma.
    Körholz D; Wirtz I; Vosberg H; Rüther W; Jürgens H; Göbel U
    Eur J Cancer; 1996 Mar; 32A(3):461-4. PubMed ID: 8814693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic appearance of uncommon soft-tissue osteogenic sarcoma metastases.
    Arrington ER; Eisenberg B; Orrison WW; Williamson MR
    J Nucl Med; 1990 May; 31(5):679-81. PubMed ID: 2341904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.
    Fletcher BD
    AJR Am J Roentgenol; 1991 Oct; 157(4):825-33. PubMed ID: 1892044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone scintigraphy in pleural metastases of osteogenic sarcoma.
    Palestro CJ; Styles ST; Kim CK; Goldsmith SJ
    Clin Nucl Med; 1990 May; 15(5):346-7. PubMed ID: 2340679
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone scintigraphy in osteosarcoma: a single institution experience.
    Powers JM; Cost C; Cederberg K; Leonard D; Leavey PJ
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e543-5. PubMed ID: 24942017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone scanning in management of metastatic osteogenic sarcoma.
    Siddiqui AR; Wellman HN; Weetman RM; Smith WL
    Clin Nucl Med; 1979 Jan; 4(1):6-11. PubMed ID: 283899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
    Bielack S; Knop J; Delling G; Winkler K
    Nuklearmedizin; 1988 Dec; 27(6):237-41. PubMed ID: 2464164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.